docosanoid anion

Term ID

CHEBI:131864

Synonyms

docosanoid anions

Definition

A polyunsaturated fatty acid anion obtained by the deprotonation of the carboxy group of any docosanoid.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: long-chain fatty acid anion

long-chain fatty acid anion Show first 5 Terms
has subtype: (4Z,7Z,10Z,13Z,16Z)-19,20-epoxydocosapentaenoate (4Z,7Z,10Z,13Z,16Z,19R,20S)-19,20-epoxydocosapentaenoate (4Z,7Z,10Z,13Z,16Z,19S,20R)-19,20-epoxydocosapentaenoate (4Z,7Z,10Z,13Z,19Z)-16,17-epoxydocosapentaenoate (4Z,7Z,10Z,16Z,19Z)-13,14-epoxydocosapentaenoate ... Show All 59 Terms

(4Z,7Z,10Z,13Z,16Z)-19,20-epoxydocosapentaenoate (4Z,7Z,10Z,13Z,16Z,19R,20S)-19,20-epoxydocosapentaenoate (4Z,7Z,10Z,13Z,16Z,19S,20R)-19,20-epoxydocosapentaenoate (4Z,7Z,10Z,13Z,19Z)-16,17-epoxydocosapentaenoate (4Z,7Z,10Z,16Z,19Z)-13,14-epoxydocosapentaenoate (4Z,7Z,11Z,13Z,15E,17S,19Z)-10,17-bis(hydroperoxy)docosahexaenoate (4Z,7Z,13Z,16Z,19Z)-10,11-epoxydocosapentaenoate (7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoate (7R,14S)-dihydroxy-(8E,10E,12Z,16Z,19Z)-docosapentaenoate (7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoate (7S,17S)-bis(hydroperoxy)-(4Z,8E,10Z,13Z,15E,19Z)-docosahexaenoate (7Z,9E,11E,16Z,19Z)-13,14-epoxydocosapentaenoate (7Z,10Z,13Z,15E,19Z)-17-oxodocosapentaenoate (7Z,10Z,13Z,16Z)-19,20-epoxydocosatetraenoate (7Z,10Z,13Z,19Z)-16,17-epoxydocosatetraenoate (7Z,10Z,14E,16Z,19Z)-13-oxodocosapentaenoate (7Z,10Z,16Z,19Z)-13,14-epoxydocosatetraenoate (7Z,13Z,16Z,19Z)-10,11-epoxydocosatetraenoate (8E,10Z,13Z,16Z,19Z)-7-oxodocosapentaenoate (8S)-cystein-S-yl-(7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoate(1-) (8S)-glutathionyl-(7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoate(2-) (8S)-glycinylcystein-S-yl-(7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoate(1-) (10R,17S)-dihydroxy-(7Z,11E,13E,15Z,19Z)-docosapentaenoate (13R)-glycinylcystein-S-yl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(1-) (13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(1-) (13R)-S-glutathionyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(2-) (13R,14S)-dihydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate (13S,14S)-epoxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate (16S,17S)-epoxy-(4Z,7Z,10Z,12E,14E,19Z)-docosahexaenoate 7,8-epoxy,17-hydroxy-(9E,11E,13Z,15E,19Z)-docosapentaenoate 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoate 7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoate 7-oxoresolvin D2(1-) 7S,14S-dihydroperoxy-(4Z,8E,10Z,12E,16Z,19Z)-docosahexaenoate(1-) 7S,14S-dihydroxy-(4Z,8E,10Z,12E,16Z,19Z)-docosahexaenoate(1-) 11S-hydroperoxy-(4Z,7Z,9E,13Z,16Z,19Z)-docosahexaenoate(1-) 13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoate 14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoate 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-) 16(S)-glutathionyl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(2-) 16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-) 16,17(S)-dihydroxy-(7Z,10Z,13E,14E,19Z)-docosapentaenoate 16-oxoresolvin D2(1-) 17R,(16)-epoxy-(4Z,7Z,10Z,13Z,19Z)-docosahexa-4,7,10,13,15,19-enoate 22-hydroxyprotectin D1(1-) dihydroxydocosahexaenoate epoxydocosahexaenoate epoxydocosapentaenoate epoxydocosatetraenoate hydroperoxydocosahexaenoate hydroperoxydocosapentaenoate hydroxydocosahexaenoate hydroxydocosapentaenoate oxodocosahexaenoate resolvin D2(1-) resolvin T1(1-) resolvin T2(1-) resolvin T3(1-) resolvin T4(1-) Show first 5 Terms
inverse is_conjugate_acid_of: docosanoid

docosanoid Show first 5 Terms
is_conjugate_base_of: docosanoid

docosanoid Show first 5 Terms

Phenotype

Phenotype resulting from docosanoid anion

Phenotype where environments contain docosanoid anion

Phenotype modified by environments containing docosanoid anion

Human Disease Model